Onderneming BioNTech SE BOERSE MUENCHEN
Aandelen
22UA
US09075V1026
Biotechnologie & Medisch Onderzoek
Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
85,05 EUR | +0,06% | +0,06% | -10,66% |
14/05 | BIONTECH SE : Evercore ISI herziet opinie en gaat over naar Neutraal | ZM |
10/05 | BIONTECH : UBS herhaalt Neutraal advies | ZD |
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Immunotherapy Technologies
100,0
%
| 18 193 | 100,0 % | 4 129 | 100,0 % | -77,31% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
78,8
%
| 13 358 | 73,4 % | 3 255 | 78,8 % | -75,63% |
Germany
12,6
%
| 3 186 | 17,5 % | 522 | 12,6 % | -83,62% |
International
8,8
%
| 1 488 | 8,2 % | 362 | 8,8 % | -75,70% |
Turkey
-0,2
%
| 162 | 0,9 % | -10 | -0,2 % | -106,09% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 02-06-08 |
Özlem Türeci
FOU | Founder | 57 | 02-06-08 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 01-07-21 |
Sierk Poetting
COO | Chief Operating Officer | 51 | 01-09-14 |
Sean Marett
COO | Chief Operating Officer | 59 | - |
Michael Horowicz
IRC | Investor Relations Contact | - | - |
James Ryan
LAW | General Counsel | - | 01-07-18 |
Ryan Richardson
PRN | Corporate Officer/Principal | 57 | 01-09-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 69 | 01-01-22 |
Director/Board Member | 67 | 02-06-08 | |
Helmut Jeggle
CHM | Chairman | 53 | 02-06-08 |
Director/Board Member | 63 | 01-01-18 | |
Director/Board Member | - | 25-05-23 | |
Anja Morawietz
BRD | Director/Board Member | 47 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 248 552 200 | 214 949 219 ( 86,48 %) | 10 826 465 ( 4,356 %) | 86,48 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
AUTOLUS THERAPEUTICS PLC 20.06% | 33 333 333 | 20.06% | 135 999 999 $ |
RYVU THERAPEUTICS S.A. 8.29% | 1 917 437 | 8.29% | 23 456 774 $ |
Bedrijfsgegevens
Sector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,66% | 111 mld. | |
+11,09% | 106 mld. | |
+0,44% | 21,25 mld. | |
-4,18% | 18,97 mld. | |
-37,85% | 18,52 mld. | |
-8,61% | 16,81 mld. | |
+38,92% | 12,54 mld. | |
-24,71% | 8,09 mld. | |
+313,68% | 7,99 mld. |
- Beurs
- Aandelen
- Koers BNTX
- Koers 22UA
- Onderneming BioNTech SE